China Kidney Disease Network (CK-NET) 2015 Annual Data Report.
Luxia Zhang,Ming-Hui Zhao,Li Zuo,Yue Wang,Feng Yu,Hong Zhang,Haibo Wang,CK-NET Work Group
DOI: https://doi.org/10.1016/j.kisu.2018.11.001
IF: 6.083
2019-01-01
Kidney International Supplements
Abstract:Kunhao Bai Department of Endoscopy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China Rui Chen Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Hong Chu Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Lanxia Gan China Standard Medical Information Research Center, Shenzhen, China Bixia Gao Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Xiangxiang He China Standard Medical Information Research Center, Shenzhen, China Lili Liu Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Jianyan Long Clinical Trial Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China Ying Shi China Standard Medical Information Research Center, Shenzhen, China Zaiming Su Center for Data Science in Health and Medicine, Peking University, Beijing, China Xiaoyu Sun Center for Data Science in Health and Medicine, Peking University, Beijing, China Wen Tang Department of Nephrology, Peking University Third Hospital, Beijing, China Fang Wang Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Haibo Wang China Standard Medical Information Research Center, Shenzhen, China; and Center for Data Science in Health and Medicine, Peking University, Beijing, China Jinwei Wang Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Song Wang Department of Nephrology, Peking University Third Hospital, Beijing, China Yue Wang Department of Nephrology, Peking University Third Hospital, Beijing, China Chao Yang Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Feng Yu Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China; and Blood Purification Center of Nephrology Department, Peking University International Hospital, Beijing, China Dongliang Zhang Blood Purification Center of Nephrology Department, Peking University International Hospital, Beijing, China Hong Zhang Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China Luxia Zhang Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China; and Center for Data Science in Health and Medicine, Peking University, Beijing, China Minghui Zhao Renal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology, Beijing, China; and Peking-Tsinghua Center for Life Sciences, Beijing, China Xinju Zhao Department of Nephrology, Peking University People's Hospital, Beijing, China Liren Zheng Blood Purification Center of Nephrology Department, Peking University International Hospital, Beijing, China Zhiye Zhou China Standard Medical Information Research Center, Shenzhen, China Li Zuo Department of Nephrology, Peking University People's Hospital, Beijing, China Tabled 1CK-NET International Advisory Committee (alphabetically)Joseph CoreshHarold FeldmanDavid JayneVivek JhaAndrew LeveyAdeera LevinVlado PerkovicPierre RoncoRajiv SaranSydney TangCK-NET Domestic Advisory Committee (alphabetically)Menghua ChenJie DingPing FuDetian LiGuisen LiShaomei LiXinling LiangYunhua LiaoHongli LinJian LiuZhangsuo LiuYingchun MaYonghui MaoLuying SunCaili WangRong WangWeiming WangWenke WangXiaoqin WangChangying XingZuying XiongXudong XuDongmei XuXiangdong YangXiaoping YangFan YiYan ZhaAihua ZhangChun ZhangJinghong ZhaoYiming ZhaoQiaoling ZhouCK-NET Technical Advisory Committee (alphabetically)Kevin HeGuilan KongXiaohua Zhou Open table in a new tab Tabled 1e6Dedicatione7Abbreviationse8Prefacee10Analytical methodse10 Introductione10 Data sourcese10HQMS databasee10CHIRA databasee10CHI databasee10COTRS databasee10 Database definitionse10Identifying CKD patientse10Identifying dialysis patientse11Cardiovascular diseasee11Diabetese11Infectious diseasee11Clinical indicatorse11Vascular accesse11 Statistical methodse12Section I. Chronic kidney diseasee12Chapter 1. Identification and characteristics of hospitalized patients with CKDe12 1.1 Prevalence of CKD among different types of underlying diseasee14 1.2 Characteristics of CKDe16 1.3 Cause of CKDe18 1.4 Staging of CKDe20Chapter 2. Cardiovascular disease in hospitalized patients with CKDe20 2.1 Prevalence of CVD, stratified by patient groupe212.1.1 Prevalence of CHDe222.1.2 Prevalence of strokee232.1.3 Prevalence of heart failuree252.1.4 Prevalence of atrial fibrillatione26 2.2 Prevalence of CVD among patients with CKDe272.2.1 Prevalence of CHD among patients with CKDe282.2.2 Prevalence of stroke among patients with CKDe302.2.3 Prevalence of heart failure among patients with CKDe312.2.4 Prevalence of atrial fibrillation among patients with CKDe32 2.3 Cardiovascular procedures stratified by patient groupe332.3.1 Cardiovascular procedures: coronarographye342.3.2 Cardiovascular procedures: percutaneous coronary interventione362.3.3 Cardiovascular procedures: coronary artery bypass graftinge372.3.4 Cardiovascular procedures: pacemakere38 2.4 Cardiovascular procedures among patients with CKDe39Chapter 3. Health care resource utilization of hospitalized patients with CKDe39 3.1 Costse393.1.1 Overall medical care costs stratified by CKD, DM, and heart failuree403.1.2 Costs stratified by types of health insurancee403.1.3 Costs stratified by sexe413.1.4 Costs stratified by agee42 3.2 Length of staye423.2.1 Overall length of stay stratified by CKD, DM, and heart failuree423.2.2 Length of stay stratified by types of health insurancee433.2.3 Length of stay stratified by sexe443.2.4 Length of stay stratified by agee45Chapter 4. In-hospital mortality of hospitalized patients with CKDe45 4.1 In-hospital mortality rate stratified by CKD, DM, and heart failuree46 4.2 In-hospital mortality rate stratified by types of insurancee46 4.3 In-hospital mortality rate stratified by sexe47 4.4 In-hospital mortality rate stratified by agee48Chapter 5. Acute kidney injurye48 5.1 Characteristics of AKIe485.1.1 Sex distribution of AKI, stratified by agee495.1.2 Age distribution of AKI, stratified by sexe50 5.2 Percentage of AKIe51 5.3 Percentage of CKD and DM among patients with AKIe53Section II. End-stage kidney diseasee53Chapter 6. Prevalence, incidence, and characteristics of dialysis patientse57Chapter 7. Clinical measurement and treatment among dialysis patientse60Chapter 8. Vascular accesse62Chapter 9. Cardiovascular diseases and diabetes among dialysis patientse63Chapter 10. Hospitalizatione66Chapter 11. Medical expenditures for dialysis patientse68Chapter 12. Kidney transplant waiting liste74Chapter 13. Discussione75Referencese76Appendices: Definitions of ICD codinge76 Appendix 1 | Coding of various CKD etiologiese77 Appendix 2 | Coding of CKD stagese78 Appendix 3 | Coding of diabetes mellituse78 Appendix 4 | Coding of hypertensione78 Appendix 5 | Coding of CVDe80 Appendix 6 | Coding of CVD operationse81 Appendix 7 | Coding of AKI Open table in a new tab The China Kidney Disease Network (CK-NET), an initiative begun by the late Professor Hai-Yan Wang in 2014, is further developed in accordance with the national strategy of prompting big data application in China. Because surveillance systems for kidney disease are insufficient in China, CK-NET has provided resourceful information and benchmark data for kidney disease. For China, a country with large population and vast territory, prompt and effective integration and mining of existing databases could be a promising strategy to improve the management of kidney disease. Further, the excellent paradigm CK-NET has set up can serve as a model for other diseases. The establishment of CK-NET is the fruit of long-term preparation and unswerving effort. After the concept of chronic kidney disease (CKD) was proposed in 2002, epidemiological study of CKD soon started to be a hot topic all over the world. I am privileged to have the opportunity to bear witness to the important work and efforts of the team led by Professor Hai-Yan Wang over the past decade. Starting from a regional survey in Beijing in 2004 to a national multicenter cross-sectional study in 2012, and then to a large-scale population cohort study in 2014, CK-NET has provided invaluable data regarding the disease burden of CKD in China, which are extremely valuable but scarce in other developing countries. As big data emerges in recent years, new methodologies and technologies have brought new opportunities for research on CKD at the population level. Against this backdrop, Professor Ming-Hui Zhao and Professor Luxia Zhang have led the CK-NET team to embark on tremendous innovative and creative tasks, such as building a team composed of nephrologists, epidemiologists, and statisticians as well as setting up a platform for data integration and sharing, efforts that greatly promoted the application of big data in the field of nephrology. The Annual Data Report (ADR) regarding kidney disease is the major output of CK-NET. The first ADR of CK-NET, which was published in 2017, focused on mostly pre-dialysis hospitalized patients in China. It is exciting to see that information regarding dialysis patients was included in this year’s ADR. This is a gift that allows China and the rest of the world to have a comprehensive understanding of characteristics and trends of kidney disease with limited resources. As the former president of the Chinese Society of Nephrology, it is my strong belief that CK-NET is a great initiative, and its contribution is a milestone for kidney disease management, prevention, and control. The ADR presented here shall provide nephrologists and health policy makers new insights into current the status of kidney disease in China. As depicted in an old Chinese poem, “10 years of effort it takes to grind this sword.” CK-NET, facilitated by big data, is developing rapidly on the solid foundation laid by its predecessors. Xue-Qing Yu, MD, PhD Former Chairman, Chinese Society of Nephrology Department of Nephrology Guangdong Provincial People’s Hospital Guangdong Academy of Medical Science Guangzhou, Guangdong, China Tabled 1ADRAnnual Data ReportAFatrial fibrillationAKIacute kidney injuryAMIacute myocardial infarctionAVFarteriovenous fistulaAVGarteriovenous graftCABGcoronary artery bypass graftingCADcoronary artery diseaseCAGcoronarographyCHDcoronary heart diseaseCHIcommercial health insuranceCHIRAChina Health Insurance ResearchCKDchronic kidney diseaseCK-NETChina Kidney Disease NetworkCOTRSChina Organ Transplant Response SystemCTINchronic tubulointerstitial nephritisCVAcerebrovascular accidentCVCcentral venous catheterCVDcardiovascular diseaseDKDdiabetic kidney diseaseDMdiabetes mellitusEPOerythropoietinESKDend-stage kidney diseaseFFBIFistula First Breakthrough InitiativeGNCKD due to glomerulonephritisHbA1chemoglobin A1cHDhemodialysisHFheart failureHQMSHospital Quality Monitoring SystemHThypertensionHTNhypertensive nephropathyIBNRincurred but not reportedICDInternational Classification of DiseasesICUintensive care unitIQRinterquartile rangei.v.intravenousLOSlength of stayMBDmineral and bone disorderNCCnoncuffed catheterNRCMSnew rural co-operative medical careONobstructive nephropathyPADperipheral arterial diseasePCIpercutaneous coronary interventionPDperitoneal dialysisPMPper million populationPPPYper person per yearPTHparathyroid hormoneRMBrenminbiSDstandard deviationTCCtunneled cuffed catheterTIAtransient ischemic attackUBMIurban basic medical insuranceUSRDSUnited States Renal Data SystemVAvascular access Open table in a new tab Chronic kidney disease (CKD) has received increased attention as a leading public health problem worldwide. Along with the rapid growth of economy and gradual changes of lifestyle, China is facing an ever-increasing burden of CKD. However, the lack of a national surveillance system for kidney disease and unmet need for nephrology research in China have become an obstacle to develop effective preventive strategies. The emergence and development of big data provided a unique opportunity to address the burden of CKD in China. After long-term planning, China Kidney Disease Network (CK-NET) was founded based on previous nationwide epidemiological studies regarding kidney disease led by Peking University First Hospital and the collaboration network involving 59 large renal centers in China (Figure 1). The mission of CK-NET is, by integrating various sources of data involving kidney disease in China and utilizing cutting-edge data analytics, to provide data-based evidence for health care policy, strengthen academic research, and promote effective disease management in the field of nephrology. In 2017, CK-NET released its first publication of an Annual Data Report (ADR), which provided useful and substantial information regarding CKD. It was published in a supplement to the American Journal of Kidney Diseases.1Zhang L. Wang H. Long J. et al.China Kidney Disease Network (CK-NET) 2014 Annual Data Report.Am J Kidney Dis. 2016; 69: S1-S149Google Scholar This year marks the second publication of a CK-NET ADR. Based on the Hospital Quality Monitoring System (HQMS), which is also the data source of the first ADR, this year’s ADR describes 887,816 hospitalized patients with CKD in 2015. Compared with the first ADR, contents that are less relevant to international readers have been deleted and certain parts (especially the cardiovascular chapter) have been enriched in the second ADR. Acute kidney injury, as an important topic, is described in a separate chapter. Furthermore, 2 more nationwide claims databases, the China Health Insurance Research (CHIRA) database and commercial health insurance (CHI) database, were included and provided information regarding dialysis in China, which enriched the contents of the ADR substantially. Seven chapters were included to provide a better understanding of end-stage kidney disease (ESKD) in China. The strengths of the second CK-NET ADR include a large patient sample size, stringent data quality control during data collection, and maximum utilization of multiple-source data. However, several points should be considered when interpreting the results in the second CK-NET ADR. First, selection bias cannot be ruled out because of limitations in data sampling. Second, International Classification of Diseases (ICD) coding is used to define CKD and certain other diseases likely with low sensitivity and high specificity, which may be influenced by various diagnostic criteria and coding procedures. Finally, the current ADR includes only cross-sectional data, making causal inference difficult. A brief interpretation is included in each chapter to facilitate understanding of the contents. The second CK-NET ADR symbolizes a successful research effort in the era of big data. It uses the platform built by the National Health Commission of the People’s Republic of China, with support from the specialists of Peking University and its affiliated hospitals. The innovative collaborative model will bring inspiration and substantial changes to health service and medical research in China. Publication of this article was supported by Peking University. All the authors declared no competing interests. We thank the National Health Commission of China, China Health Insurance Research Association, China Organ Transplantation Development Foundation, Peking University, and China Standard Medical Information Research Center for support of this study. We thank CK-NET collaborating centers, members, and volunteers for their hard work and efforts. We thank every participant who has contributed important and invaluable data to CK-NET.